Emerg Infect Dis by Murray, Gerald L. et al.
 Page 1 of 3 
Article DOI: http://dx.doi.org/10.3201/eid2305.161745 
Macrolide and Fluoroquinolone Resistance in Mycoplasma 
genitalium  
Technical Appendix 
Technical Appendix Figure. Comparison of amino acid sequence changes in Mycoplasma genitalium ParC and GyrA. The amino acid 
sequences from strain G37 were aligned, and the relevant portion of the sequence is presented, with identical residues indicated in boldface. 
Numbers refer to the amino acid sequence number from the M. genitalium sequence. Changes in sequence at specific residues are indicated by 
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letters enclosed by shading, either above the alignment (GyrA) or below (ParC). The relevant study is indicated on the right. A boxed letter 
indicates that the change has been linked with fluoroquinolone treatment failure. Circled amino acids in the primary sequences indicate residues 
that may be directly involved in fluoroquinolone binding. + indicates silent mutation. 
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